Aurora Cannabis (ACB) Non Operating Interest Expenses (2017 - 2026)

Aurora Cannabis (ACB) has reported Non Operating Interest Expenses for 10 consecutive years, with -$335437.3 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 4.37% year-over-year to -$335437.3 in Q2 2026; TTM through Jun 2026 was -$328994.8, a 66.83% increase from a year earlier, with the FY2026 full-year figure at -$1.3 million, up 27.65% from the prior year.
• Non Operating Interest Expenses was -$335437.3 for Q2 2026 at Aurora Cannabis, down from $3.1 million in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $3.1 million in Q1 2026 and troughed at -$26.5 million in Q4 2022.
• A 5-year average of -$5.4 million and a median of -$1.5 million in 2025 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses tumbled 190.11% in 2022 and surged 259.84% in 2025, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at -$26.5 million in 2022, then soared by 93.06% to -$1.8 million in 2023, then advanced by 23.0% to -$1.4 million in 2024, then retreated by 6.76% to -$1.5 million in 2025, then soared by 77.79% to -$335437.3 in 2026.
• The last three Non Operating Interest Expenses figures came in at -$335437.3 (Q2 2026), $3.1 million (Q1 2026), and -$1.5 million (Q4 2025), per Business Quant data.